Kamari Pharma is a clinical stage biotechnology company developing “first and best in class” treatments of rare and severe genetic skin diseases, such as Keratoderma and Ichthyosis.

Content Locked
Login or Register a FREE account to continue browsing our content
2018
Tel Aviv, Israel

11 - 50
Series A| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content